Alumis ALMS
NASDAQ ALMS
$7.20 -0.01 (-0.21%)
As of: Oct 2, 2026 · 10:24 AM EDT

Alumis (ALMS) Accumulated Expenses (2023 - 2026)

Updated

Alumis' Accumulated Expenses was $35.57 million in Q2 2026, down 18.7% from $43.73 million a year earlier.

Analysis

Alumis (ALMS) Accumulated Expenses (2023 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Alumis came in at $34.78 million, up 19.3% from FY2024.

  • In earlier years, Accumulated Expenses was $29.15 million in FY2024 (+166.3%) and $10.95 million in FY2023.
  • Quarterly Accumulated Expenses has moved between $10.95 million (Q4 2023) and $43.73 million (Q2 2025) over five years.
  • Compared with a year earlier, Accumulated Expenses was higher in four of the last five quarters, with growth averaging 94.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Alumis 919.65 Mn -755.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.57 Mn
Dec 31, 2025 34.78 Mn
Sep 30, 2025 37.63 Mn
Jun 30, 2025 43.73 Mn
Mar 31, 2025 34.70 Mn
Dec 31, 2024 29.15 Mn
Sep 30, 2024 18.14 Mn
Jun 30, 2024 14.58 Mn
Dec 31, 2023 10.95 Mn
API Access

Alumis Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ALMS&period=max&api_key=YOUR_API_KEY